Medical Affairs Intern, Genitourinary & Gynecological Oncology jobs in United States
cer-icon
Apply on Employer Site
company-logo

AstraZeneca · 17 hours ago

Medical Affairs Intern, Genitourinary & Gynecological Oncology

AstraZeneca is seeking a Medical Affairs Intern for a 12-week internship role in Gaithersburg, MD. The intern will build and execute a targeted Urologists engagement program, supporting studies and co-developing medical education initiatives.

BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Discovery & KOL mapping, initial outreach and baseline insight interviews
Engage in deep insight synthesis, congress planning (speaker selection, draft agenda), and medical education concept co‑creation
Finalize congress & education deliverables, stakeholder review & approvals, measurement setup and project handover at end of assignment

Qualification

Project managementPharmaceutical industry experienceOncology experienceMedical affairs understandingPublic speakingPresentation designCollaboration

Required

Junior and Master's students majoring in Biological Sciences, Pharmaceutical Sciences, or a related field
Candidates must have an expected graduation date after August 2026
Experience with project management with ability to deliver on time and on budget
Prior experience in the pharmaceutical industry is a plus
Experience in Oncology, TA preferred
Basic understanding of medical affairs and describing the impact of our activities for leadership updates
Ability to function collaboratively, including external partner management
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design
US Work Authorization is required at time of application
Ability to report onsite to Gaithersburg, MD site 3 days per week

Company

AstraZeneca

company-logo
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.

Funding

Current Stage
Public Company
Total Funding
$5.26B
2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B

Leadership Team

leader-logo
Pascal Soriot
Executive Director and Chief Executive Officer
leader-logo
Aradhana Sarin
Group CFO and Executive Director
linkedin
Company data provided by crunchbase